Back to Search Start Over

The role of 5-arylalkylamino- and 5-piperazino- moieties on the 7-aminopyrazolo[4,3-d]pyrimidine core in affecting adenosine A 1 and A 2A receptor affinity and selectivity profiles.

Authors :
Squarcialupi L
Betti M
Catarzi D
Varano F
Falsini M
Ravani A
Pasquini S
Vincenzi F
Salmaso V
Sturlese M
Varani K
Moro S
Colotta V
Source :
Journal of enzyme inhibition and medicinal chemistry [J Enzyme Inhib Med Chem] 2017 Dec; Vol. 32 (1), pp. 248-263.
Publication Year :
2017

Abstract

New 7-amino-2-phenylpyrazolo[4,3-d]pyrimidine derivatives, substituted at the 5-position with aryl(alkyl)amino- and 4-substituted-piperazin-1-yl- moieties, were synthesized with the aim of targeting human (h) adenosine A <subscript>1</subscript> and/or A <subscript>2A</subscript> receptor subtypes. On the whole, the novel derivatives 1-24 shared scarce or no affinities for the off-target hA <subscript>2B</subscript> and hA <subscript>3</subscript> ARs. The 5-(4-hydroxyphenethylamino)- derivative 12 showed both good affinity (K <subscript>i</subscript> = 150 nM) and the best selectivity for the hA <subscript>2A</subscript> AR while the 5-benzylamino-substituted 5 displayed the best combined hA <subscript>2A</subscript> (K <subscript>i</subscript> = 123 nM) and A <subscript>1</subscript> AR affinity (K <subscript>i</subscript> = 25 nM). The 5-phenethylamino moiety (compound 6) achieved nanomolar affinity (K <subscript>i</subscript> = 11 nM) and good selectivity for the hA <subscript>1</subscript> AR. The 5-(N <superscript>4</superscript> -substituted-piperazin-1-yl) derivatives 15-24 bind the hA <subscript>1</subscript> AR subtype with affinities falling in the high nanomolar range. A structure-based molecular modeling study was conducted to rationalize the experimental binding data from a molecular point of view using both molecular docking studies and Interaction Energy Fingerprints (IEFs) analysis.[Formula: see text].

Details

Language :
English
ISSN :
1475-6374
Volume :
32
Issue :
1
Database :
MEDLINE
Journal :
Journal of enzyme inhibition and medicinal chemistry
Publication Type :
Academic Journal
Accession number :
28114825
Full Text :
https://doi.org/10.1080/14756366.2016.1247060